MedTrace Logo

Lymphedema Severity on Shoulder Joint Function and Muscle Activation Patterns in Breast Cancer Survivors

NCT05934695 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2024-01-22

No results posted yet for this study

Summary

Breast cancer-related lymphedema (BCRL) is a common complication affecting the upper extremity following breast cancer treatment. This study aims to investigate the relationship between lymphedema severity and shoulder joint function and muscle activation patterns in breast cancer survivors.

Conditions

Interventions

OTHER

Lymphedema severity stratification

Participants will be stratified into one of three lymphedema severity groups based on the International Society of Lymphology lymphedema severity staging: Mild (stage 1): swelling with pitting; normal skin and tissue turgor Moderate (stage 2): swelling with pitting; dermal thickening; skin changes without distortional warty-overgrowth Severe (stage 3): swelling with non-pitting; warty overgrowth or elephantiasis folds

Sponsors & Collaborators

  • Ahram Canadian University

    lead OTHER

Principal Investigators

  • Amal Fawzy, Ph.d · Faculty of Physical Therapy, Ahram Canadian University

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-30
Primary Completion
2024-01-03
Completion
2024-01-03

Countries

  • Egypt

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05934695 on ClinicalTrials.gov